Actively Recruiting
Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension. A Randomized Controlled Trial.
Led by Heinrich-Heine University, Duesseldorf · Updated on 2025-03-12
60
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of anti-hypertensive treatment combined with individualized exercise training on blood pressure and vascular health in patients with hypertension. This randomized controlled trial aims to understand how these treatments impact vascular function and metabolism, helping to improve personalized medicine approaches for managing hypertension through sensitive vascular biomarkers. Participants will be randomly assigned to one of two groups. One group receives guideline-based anti-hypertensive therapy plus an individualized exercise program three times a week, including aerobic and resistance training tailored to each patient's fitness level, supported by regular contact with exercise physiologists and group sessions. The other group receives guideline-based anti-hypertensive therapy alongside general lifestyle advice such as salt reduction, increased physical activity, and stress management. Throughout the one-year study, including a six-month treatment period and a six-month follow-up, participants will attend outpatient visits every two months for blood pressure checks and assessments of large and small blood vessels. Researchers will measure retinal vessel diameters, blood pressure, microvascular endothelial function, arterial stiffness, physical fitness, metabolic profiles, and inflammation markers. These evaluations will help determine the vascular and metabolic effects of treatment and exercise interventions over time.
CONDITIONS
Brief Title
Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Systolic hypertension grade I-II with blood pressure values greater than 140 mmHg and less than 180 mmHg
- No prior anti-hypertensive medication treatment
- Adults aged 18 years or older
You will not qualify if you...
- No written informed consent
- Age less than 18 years
- Isolated diastolic hypertension
- Medical contraindications for exercise treatment such as orthopedic problems or abnormal ECG during cardio respiratory exercise test
- Chronic eye diseases affecting both eyes, such as macular degeneration or glaucoma, or high intraocular pressure above 20 mmHg
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants receive guideline-based anti-hypertensive therapy. Additionally, those in the intervention group follow an individualized exercise training program 3 times per week, including aerobic and resistance training tailored to their fitness level, while the control group receives general lifestyle recommendations.
Outpatient visits every 2 months
Duration - 6 months
Participants continue to be observed for long-term effects of anti-hypertensive therapy with or without individualized exercise training on blood pressure and vascular health.
Outpatient visits every 2 months
Trial Site Locations
Total: 1 location
1
Universitätsklinik Düsseldorf
Düsseldorf, Düsseldorf, Germany, 40225
Actively Recruiting
Research Team
J
Johannes Stegbauer, Prof. Dr.
L
Lukas Streese, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here